EKMAN LARS received a stock award from ULTRAGENYX PHARMACEUTICAL INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/28/2022ACC: 0001209191-22-039567
+9.54K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
9.54K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.30K
Price / share
—
Trade value
—
% of position
22.8%
6/24/2022
14.45K→17.75K
Total
Net shares
+3.30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/24/2022 | A · Award | +3.30K | — | — | 22.8% | 14.45K | 17.75K |
| Total | +3.30K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
6.25K shares
Shares
+6.25K
Strike price
60.57
Held after
6.25K
Exercisable
—
6/24/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock6.25K shares | 6/24/2022 | A · Award | +6.25K | 60.57 | — | 6.25K |